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Summary 
Elovl4 is a fatty acyl elongase that participates in the biosynthesis of very long-chain 
fatty acids (≥C24), which are relatively abundant in skin (saturated chains), or retina, 
brain and testes (polyunsaturated chains) of mammals. In the present study we 
characterised two Elovl4 proteins, Elovl4a and Elovl4b, from zebrafish Danio rerio, 
and investigated their expression patterns during embryonic development. 
Heterologous expression in baker’s yeast showed that both zebrafish Elovl4 proteins 
efficiently elongated saturated fatty acids up to C36, with 26:0 appearing the preferred 
substrate as reported for human ELOVL4. Interestingly, activity for the elongation of 
PUFA substrates was only shown by Elovl4b, which effectively converted 
eicosapentaenoic (20:5n-3) and arachidonic (20:4n-6) acids to elongated polyenoic 
products up to C36. Furthermore, zebrafish Elovl4b may be involved in the 
biosynthesis of docosahexaenoic acid (22:6n-3, DHA) as it had the capacity to 
elongate 22:5n-3 to 24:5n-3 which can be subsequently desaturated and chain 
shortened to DHA in peroxisomes. The distinct functional roles of zebrafish Elovl4 
proteins were also reflected in their spatial-temporal expression patterns during 
ontogeny. Analyses by whole-mount in situ hybridisation in zebrafish embryos 
showed that elovl4a was expressed in neuronal tissues (wide-spread distribution in the 
head area), with elovl4b specifically expressed in epiphysis (pineal gland) and 
photoreceptor cells in the retina. Similarly, tissue distribution in adults revealed that 
elovl4a transcripts were found in most tissues analysed, whereas elovl4b expression 
was essentially restricted to eye and gonads. Overall, the results suggest that zebrafish 
elovl4b resembles other mammalian orthologues in terms of function and expression 
patterns, whereas elovl4a may represent an alternative elongase not previously 
described in vertebrates. 
Introduction 
Elongases of very long-chain fatty acids (Elovl) are the initial and rate-limiting 
enzymes responsible for the condensation reaction required for biosynthesis of long-
chain fatty acids (FA) [1]. Seven members of the Elovl family, termed ELOVL 1-7, 
have been identified in mammals that differ from each other in their substrate 
specificity [2-4]. Generally speaking, mammalian ELOVL1, ELOVL3, ELOVL6 and 
ELOVL7 are involved in elongation of saturated and monounsaturated FAs, whereas 
ELOVL2 and ELOVL5 elongate polyunsaturated fatty acids (PUFAs). The functional 
role of ELOVL4 in fatty acid biosynthesis was later ascertained. 
ELOVL4 was first identified as a gene causing a dominant form of Stargardt-
like macular dystrophy (STGD3). Three distinct mutations in the last exon (exon-VI), 
a 5-bp [5], two 1-bp [6], and a nonsense mutation [7] in the ELOVL4 gene were 
predicted to introduce a premature stop codon resulting in a truncated ELOVL4 
protein lacking the putative endoplasmatic reticulum (ER) dilysine retention signal 
(KXKXX). Subsequent investigations revealed that truncated ELOVL4 is not retained 
in the ER and misplaces wild type ELOVL4 to non-ER aggregates [8-10]. In addition 
to its localisation in the ER, the site of long-chain fatty acid synthesis [11], the 
similarities between the amino acid sequence of human ELOVL4 with other elongase 
family proteins and its high expression levels in tissues having high requirements for 
very long-chain fatty acids (VLC-FA), suggested a role for ELOVL4 in FA 
biosynthesis.  
    Previous investigations demonstrated that ELOVL4 is required for generating 
saturated VLC-FAs (i.e. carbon chain C ≥ 28) that are components of sphingolipids 
and ceramides [12-15]. Additionally, ELOVL4 was speculated to participate in the 
synthesis of very long-chain PUFAs (VLC-PUFAs), as STGD3 mutation reduced 
retinal levels of C32-C36 acyl phosphatidylcholines (PCs) in mouse retinal extracts 
[16]. The dual role of human ELOVL4 was recently confirmed by Agbaga and co-
workers who demonstrated that the enzyme is active both in the elongation of 
saturated VLC-FA 26:0 to 28:0 and 30:0, and in the biosynthesis of VLC-PUFAs 
ranging from C28-C38 [17].  
Saturated VLC-FAs are abundant compounds in the epidermis of mammals, 
where they perform essential structural functions in the maintenance of skin 
permeability [18]. Although less clear, the functions of VLC-PUFAs appear to be 
related to their unusually long aliphatic chains (C24-C38) and the concomitant 
characteristic that some VLC-PUFAs possess by combining the properties of 
saturated fatty acid in the proximal end with those of PUFA in the distal end [17]. 
Thus, VLC-PUFAs are compounds uniquely found in specific lipid molecules of 
retina [19,20], brain [21,22] and testis [23-25].  
Since their discovery more than two decades ago, studies of VLC-FA and their 
metabolism in vertebrates have revealed their prominent role in processes such as 
vision, brain functioning, reproduction and skin permeability [19,22,26]. It is thus 
important to investigate the molecular mechanisms underlying the biosynthetic 
pathways of VLC-FA in early developmental stages at the onset of many of these 
physiological processes. Zebrafish (Danio rerio), a popular model organism in 
vertebrate developmental biology, has recently been used to study several aspects of 
lipid metabolism [27-30]. Zebrafish possess two genes encoding putative Elovl4 
elongases, termed as elovl4a (gb|NM_200796|) located in chromosome 16 and 
elovl4b (gb|NM_199972|) in chromosome 23. Their functional roles and expression 
profiles during ontogeny were unknown. 
The present study aimed to characterise the two putative Elovl4 enzymes from 
Danio rerio, and to investigate their expression patterns during development. Firstly, 
we isolated both elovl4 cDNAs, elovl4a and elovl4b, analysed their sequences, and 
studied their function by expressing their open reading frames (ORF) in recombinant 
yeast incubated with appropriate fatty acid substrates. Subsequently, the spatial-
temporal expression patterns of elovl4a and elovl4b were investigated during 
zebrafish embryogenesis, in order to identify the distinct biological processes the 
genes are involved in during early development of vertebrates. 
 
Materials and methods 
Fish maintenance 
Zebrafish embryos were cultured as previously described [31] and staged by standard 
criteria [32] or by hours (hpf) or days (dpf) post fertilisation. Experiments were 
performed using the AB wild-type strain. For whole-mount in situ hybridisation 
analyses, dechorionated embryos were fixed overnight at 4 ºC in 4 % 
paraformaldehyde in 1xPBS, washed in PBS, and dehydrated through a methanol 
series, and stored at -20 ºC in 100 % methanol. To inhibit embryo pigmentation, 
embryo medium was supplemented with 0.003 % 1-phenyl-2-thiourea (PTU, Sigma) 
[31].  
 
Zebrafish elovl4: cloning and functional characterisation by heterologous expression 
in Saccharomyces cerevisiae 
PCR fragments corresponding to the ORF of the putative zebrafish elovl4a 
(gb|NM_200796|) and elovl4b (gb|NM_199972|) were amplified from ovary and 
whole-eye cDNA, respectively, using the high fidelity Pfu Turbo DNA polymerase 
(Stratagene, Agilent Technologies, Cheshire, UK). A nested PCR approach was used 
with a first round performed with specific primer pairs (Table 1) Elovl4aU5F / 
Elovl4aU3E (elovl4a) and Elovl4bU5F / Elovl4bU3E (elovl4b). PCR conditions 
consisted of an initial denaturing step at 95 ºC for 2 min, followed by 33 cycles of 
denaturation at 95ºC for 30 s, annealing at 58 (elovl4a) or 55 ºC (elovl4b) for 30 s, 
extension at 72 ºC for 1 min 20 s, followed by a final extension at 72 ºC for 5 min. 
First round PCR products were used as template for the nested PCR with thermal 
conditions as described above, and with primers containing restriction sites 
(underlined in Table 1) Elovl4bVF (Hind III) and Elovl4aVR (Xho I) for elovl4a and 
Elovl4bVF (Hind III) and Elovl4bVR (Xho I) for elovl4b. 
    The DNA fragments containing zebrafish elovl4 forms were then digested with the 
corresponding restriction endonucleases (New England BioLabs, Herts, UK) and 
ligated into a similarly restricted pYES2 yeast expression vector (Invitrogen, Paisley, 
UK). The purified plasmids (GenElute™ Plasmid Miniprep Kit, Sigma) containing 
the putative elovl4 ORFs were used to transform S. cerevisiae competent cells (S.c. 
EasyComp Transformation Kit, Invitrogen). Transformation and selection of yeast 
with recombinant pYES2-elovl4 plasmids and yeast culture were performed as 
described in detail previously [33,34]. Briefly, cultures of recombinant yeast were 
grown in S. cerevisiae minimal medium-uracil supplemented with one of the 
following FA substrates: lignoceric acid (24:0), eicosapentaenoic acid (20:5n-3), 
arachidonic acid (20:4n-6), docosapentaenoic acid (22:5n-3), docosatetraenoic acid 
(22:4n-6) or docosahexaenoic acid (22:6n-3). Docosapentaenoic and docosatetraenoic 
acids (>98-99 % pure) were purchased from Cayman Chemical Co. (Ann Arbor, 
USA) and the remaining FA substrates (>99 % pure) and chemicals used to prepare 
the S. cerevisiae minimal medium-uracil were from Sigma Chemical Co. Ltd. (Dorset, 
UK). Lignoceric acid was dissolved in α-cyclodextrin [35] at 5 µM and added to the 
yeast cultures at a final concentration of 0.6 µM, whereas PUFA substrates were 
added at final concentrations of 0.75 (C20) and 1.0 (C22) mM. After 2 days, yeast 
were harvested and washed for further analyses. Yeast transformed with pYES2 
containing no insert were cultured under the same conditions as a control treatment. 
 
FAME analysis by GC-MS 
Total lipids from yeast were extracted by homogenisation in chloroform/methanol 
(2:1, v/v) containing 0.01% BHT as antioxidant. FA methyl esters (FAMEs) were 
subsequently prepared, extracted and purified [33]. FAMEs were identified and 
quantified using a gas chromatograph (GC8000) coupled to an MD800 mass 
spectrometer (ThermoFisher Scientific, Hemel Hempstead, UK). Samples were 
applied by on-column injection using an AS800 autosampler (ThermoFisher 
Scientific, Hemel Hempstead, UK). The gas chromatograph was equipped with a ZB-
Wax silica capillary column (30 m x 0.32 mm x 0.25 µm; Phenomenex, Macclesfield, 
UK). Helium carrier gas was used with a column head pressure of 15 psi. The oven 
temperature was programmed to rise from 80 to 260 ºC. The GC-MS was operated in 
the electron ionisation (EI) single ion monitoring (SIM) mode. The 24:0, 26:0, 28:0, 
30:0, 32:0, 34:0 and 36:0 response values were obtained by using the m/z ratios 382.4 
410.4, 438.4, 466.5, 494.5, 522.5 and 550.5, respectively. For VLC-PUFA analysis, 
the response values were obtained by using the m/z ratios 79.1, 108.1 and 150.1 in 
SIM mode. Elongation rates from PUFA substrates were calculated by the proportion 
of substrate FA converted to elongated FA product as [product area/(product area + 
substrate area)] x 100. Conversion rates from 24:0 were not calculated as yeast 
endogenously contains several of the FA involved in the elongation pathway. 
Alternatively, individual ≥ C24 saturated FA contents from elovl4-transformed yeast 
were calculated and compared to control yeast. 
 
Sequence and phylogenetic analysis of Elovl4 
The amino acid (AA) sequences deduced from Danio rerio Elovl4a 
(gb|NP_957090.1|) and Elovl4b (gb|NP_956266.1|) cDNAs were aligned using 
ClustalW2, and compared with other orthologues of human (gb|NP_073563.1|), 
mouse (gb|NP_683743.2|) and rat (gb|XP_001062735.1|) Elovl4s, bird Taenopygia 
guttata (gb|XP_002188735.1|) and Gallus gallus (gb|XP_419868.2|), and fish 
Tetraodon nigroviridis (emb|CAG01780|) and Takifugu rubripes (derived from EST 
emb|ENSTRUT00000011027|) predicted Elovl4-like proteins using the EMBOSS 
Pairwise Alignment Algorithms tool (http://www.ebi.ac.uk/Tools/emboss/align/). A 
phylogenetic tree was constructed on the basis of the AA sequence alignments 
between the putative zebrafish Elovl4s, vertebrate Elovl4 orthologues, and Elovl2- 
and Elovl5-like proteins using the Neighbour Joining method [36]. Confidence in the 
resulting phylogenetic tree branch topology was measured by bootstrapping through 
1000 iterations. 
 
Temporal expression of zebrafish elovl4 genes  
The expression of zebrafish elovl4 genes during the embryonic development was 
studied by reverse transcriptase PCR (RT-PCR). Total RNA was extracted from pools 
of 20-30 embryos collected at 0, 2, 3, 6, 9, 12, 14 and 19 hpf, and 1, 2, 3, 4, 5, 6 and 7 
dpf using Tri Reagent (Sigma) according to manufacturer’s protocol. Five µg of total 
RNA was reverse transcribed into cDNA using M-MLV reverse transcriptase first 
strand cDNA synthesis kit (Promega, Madison, USA). RT-PCRs performed on cDNA 
samples consisted of an initial denaturing step at 95 ºC for 2 min, followed by 35 
cycles of denaturation at 95 ºC for 30 s, annealing at 60 ºC for 30 s, and extension at 
72 ºC for 1 min, followed by a final extension at 72 ºC for 5 min. Expression of β-
actin was also determined as reference gene [37]. Primers used for RT-PCR on 
embryos cDNA samples are shown in Table 1. 
 
Spatial expression of elovl4s, whole-mount in situ hybridization 
To examine the spatial expression of zebrafish Elovl4a and Elovl4b, whole-mount in 
situ hybridisation (WISH) was performed on 24, 48 and 72 hpf zebrafish embryos 
using Digoxygenin (DIG)-labelled antisense riboprobes as previously described [38]. 
Antisense riboprobes were made from linerarised partial length D. rerio elovl4a and 
elovl4b sequences. To increase hybridisation specificity, sequences containing part of 
the untranslated region (UTR) were chosen. Thus, elovl4a probe was 567 bp (from nt 
886 to 1453) in length, containing 228 bp of coding region and 339 bp of 3’UTR (gb| 
NM_200796|). The elovl4b probe was 507 bp (from nt 144 to 650) in length, 
containing 469 bp of coding region and 38 bp of 5’UTR (gb|NM_199972|). 
 
Tissue distribution of zebrafish Elovl4 
Total RNA from muscle, intestine, liver, brain, gill, testis, ovary, eye, posterior 
kidney, heart, spleen, skin, adipose tissue, anterior kidney and whole fish was 
extracted and cDNA synthesised as described for embryo samples. Tissue expression 
of zebrafish elovl4 elongases was analysed by RT-PCR (GoTaq Polymerase, 
Promega) on cDNA samples, with thermal conditions identical to those detailed 
above for embryos. Expression of the housekeeping β-actin was also determined to 
check the cDNA integrity. Primers used for RT-PCR on tissue cDNA samples are 
shown in Table 1. 
 
Results 
Elovl4 sequence and phylogenetics 
The D. rerio elongases elovl4a and elovl4b ORFs encode proteins of 309 and 303 
AA, respectively. Zebrafish Elovl4 both possess the diagnostic histidine box HXXHH 
motif conserved in all elongases, five membrane spanning domains, and the 
endoplasmic reticulum (ER) retrieval signal RXKXX (Elovl4a) and KXKXX 
(Elovl4b) at the carboxyl terminus (Fig. 1). Zebrafish Elovl4a and Elovl4b proteins 
share, respectively, 64.4 - 65.2 % AA identity to mammalian homologues, and 62.9 - 
64.8 % identity with predicted Elovl4 sequences from birds. When AA sequences of 
zebrafish Elovl4s are compared to fish predicted Elovl4s, two groups appear to exist, 
with Elovl4a and Takifugu rubripes Elovl4 in one group (81.1 % identity), and 
Elovl4b and Tetraodon nigroviridis Elovl4 in the other (82.4 % identity). Identity 
scores within these two groups are higher than that of zebrafish Elovl4 proteins when 
compared to each other (73.8 % identity). Differentiation among fish Elovl4 proteins 
is reflected in the phylogenetic analysis (Fig. 2), with zebrafish Elovl4a clustering 
together with T. rubripes Elovl4, and zebrafish Elovl4b more closely with pufferfish 
T. nigroviridis predicted Elovl4. All fish Elovl4 elongases group with the mammalian 
and bird orthologues, and separately from other members of the Elovl family such as 
Elovl2 and Elovl5 from fish and mammalian (Fig. 2).  
 
Functional characterisation 
The zebrafish putative Elovl4 elongases were functionally characterised by 
determining the FA profiles of S. cerevisiae transformed with pYES2 containing 
elovl4 inserts isolated from ovary (elovl4a) and eye (elovl4b) and grown in the 
presence of potential FA substrates. To test the ability of zebrafish Elovl4 to elongate 
saturated VLC-FA, yeast transformed with pYES2 containing the putative elovl4 
coding region cDNAs or no insert (control) were incubated with lignoceric acid (24:0) 
(Table 2; Fig. 3). The results confirm that zebrafish Elovl4s are both involved in the 
biosynthesis of saturated VLC-FAs. Thus, control yeast transformed with empty 
vector and incubated with 24:0 (lignoceric acid) contained measurable amounts of 
24:0 (9.2% of total saturates ≥ C24), 26:0 (80.2%) and 28:0 (7.5%), with traces of 
longer FAs up to C34 (Table 2). Importantly, elovl4 transformed yeast showed a 
different profile of saturated FAs ≥ C24 compared to control yeast, with decreased 
contents of 26:0 and increased levels of 28:0 (3.5- and 4.5-fold, for elovl4a and 
elovl4b, respectively), 30:0 (13.7- and 10.1-fold, for elovl4a and elovl4b, 
respectively) and 32:0 (13.5- and 3.5-fold, for elovl4a and elovl4b, respectively) 
(Table 2). These results suggest that 26:0 is a preferred substrate for both zebrafish 
Elovl4 proteins. 
    In order to test the role of D. rerio Elovl4 elongases in VLC-PUFA biosynthetic 
pathway, yeast transformed with zebrafish Elovl4s were incubated with C20 (20:5n-3 
and 20:4n-6) and C22 (22:5n-3, 22:4n-6 and 22:6n-3) PUFAs. The FA composition of 
the yeast transformed with pYES2 vector containing no insert is characterised by 
having only 16:0, 16:1n-7, 18:0 and 18:1n-9, together with whichever exogenous FA 
was added, consistent with S. cerevisiae possessing no PUFA elongase activity [34]. 
GC-MS analyses revealed that zebrafish Elovl4a elongated 20:5n-3 and 20:4n-6 with 
up to 16.0 % and 20.3 % of each converted, respectively (Table 3). Elovl4a elongated 
C22 PUFA substrates to a much lower extent (Table 3). Zebrafish Elovl4b, however, 
showed higher activity than Elovl4a towards 20:5n-3 and 20:4n-6, but especially 
towards C22 substrates 22:5n-3 and 22:4n-6. Conversions produced by elovl4b-
transformed yeast included polyenes up to C36, with C32 PUFA consistently being 
the most abundant product (Table 3; Fig. 4). It is noteworthy that both zebrafish 
Elovl4 elongases are able to convert 20:5n-3 or 22:5n-3 to 24:5n-3, an intermediate 
substrate for ∆6 fatty acyl desaturase involved in 22:6n-3 (DHA) synthesis. However, 
in contrast zebrafish Elovl4s have virtually no activity towards DHA itself (Fig. 4C). 
 
Spatial-temporal expression of zebrafish elovl4 genes 
Temporal expression of elovl4a and elovl4b were studied by RT-PCR on cDNA 
samples obtained from embryos at different developmental stages from 0 to 7 dpf 
(Fig. 5). Results reveal that the two genes are expressed from the zygote stage, with 
transcripts detected throughout embryonic development (Fig. 5). 
    To determine the spatial expression patterns of elovl4a and elovl4b, an in situ 
whole-mount hybridisation time course was performed using wild-type zebrafish 
embryos. Elovl4a was widely distributed in the head region of 24 (Fig. 6A), 48 and 72 
hpf embryos (data not shown). Unlike elovl4a, elovl4b was specifically expressed in 
the pineal gland (epiphysis) and the photoreceptor cell layer of the retina (Fig 7A-H). 
Elovl4b transcripts first appear in the pineal gland at 24 hpf (Fig. 7A, B), and remain 
in this site until around 48 hpf (Fig. 7C, D). At 48 hpf, elovl4b hybridisation signal 
also appears in the ventral area of developing retina (Fig. 7C, E). At 72 hpf, elovl4b 
transcripts become localised in the ventral portion of the retina photoreceptor cell 
layer, in the so-called ‘‘ventral patch’’(Fig. 7F, G, H). No signal was detected for 
sense control probes of elovl4a (Fig. 7B) and elovl4b genes (data not shown). 
    Tissue distribution of elovl4 mRNAs in adult zebrafish was analysed by RT-PCR. 
Elovl4a transcripts were detected in most tissues analysed including liver, with 
muscle and adipose tissue not showing expression signal (Fig. 8). A more restricted 
pattern was observed for elovl4b, with high expression found in eye, ovary and testis 
(Fig. 8).  
 
Discussion 
    The overall objective is to elucidate the molecular mechanisms controlling long-
chain polyunsaturated fatty acid (LC-PUFA) biosynthesis in developing vertebrates as 
these fatty acids have critical biological functions during early ontogeny [39-42]. In a 
recent study investigating the activation of genes involved in the LC-PUFA 
biosynthesis pathway during zebrafish embryogenesis [43], we functionally 
characterised an Elovl2-like elongase that efficiently elongated C20 and C22 PUFA, 
and so had different substrate specificity to the formerly cloned Elovl5-like elongase 
[34], which was more active on C18 and C20 PUFA. In the present study, we 
characterised zebrafish Elovl4a and Elovl4b elongases, two further members of the 
Elovl protein family involved in fatty acid elongation in this vertebrate model.  
    Human ELOVL4, thus far being the only Elovl4-like protein functionally 
characterised, was demonstrated to participate in the biosynthesis of saturated VLC-
FA ≥ C28 [17]. Decreased proportions of 26:0 and concomitant increased percentages 
of 28:0 and 30:0 in zebrafish elovl4-transformed yeast suggests that both zebrafish 
Elovl4s are involved in the synthesis of 28:0 and 30:0 from 26:0. Thus, Elovl4a and 
Elovl4b appear capable of producing saturated VLC-FA up to C36 from shorter-chain 
fatty acids. This is consistent with the conversions shown by human ELOVL4. Cell 
lines not naturally expressing ELOVL4 showed decreased 26:0 levels and increased 
levels of 28:0 and 30:0 when transformed with human ELOVL4 [17]. Similar 
conclusions were obtained in genetically engineered mice lacking a functional Elovl4 
protein, which showed increased levels of C26 FA and depletion of ≥C28 in lipids of 
the epidermal stratum corneum that altered the skin barrier function, and ultimately 
caused dehydration and perinatal death [12-15]. Apart from the essential role of 
Elovl4 for the formation of saturated ≥C28, ELOVL4 is also required for biosynthesis 
of VLC-PUFA [17,44], and so represents the first Elovl protein with dual substrate 
specificity for saturated and unsaturated VLC-FA [45].  
    The role of both zebrafish Elovl4 proteins in VLC-PUFA biosynthesis shows 
particular differences compared not only to mammalian Elovl4 proteins, but also to 
each other. On one hand, zebrafish Elovl4a does not appear to take part in the VLC-
PUFA biosynthetic pathway, as only relevant conversions were observed on C20 
PUFA substrates, with C22 PUFA remaining virtually unmodified. In contrast, 
zebrafish Elovl4b is very active towards both C20 and C22 PUFA substrates, 
producing polyenes up to C36 of the n-3 and n-6 series. This is in agreement with 
previous studies on human ELOVL4, which was seen to produce VLC-PUFAs [17], 
and mutated Elovl4-knockin mice showing deficiencies in C32-C36 
phosphatidylcholines in retina [16]. However, contrary to human ELOVL4, zebrafish 
Elovl4b may participate in the biosynthesis of DHA, as it is able to convert 22:5n-3 to 
24:5n-3, which can be further desaturated and chain-shortened to form DHA [46]. 
This role of Elovl4 in fish might be crucial in marine species, where lack of Elovl2 
has been speculated to be one possible cause of their low LC-PUFA biosynthetic 
capability [43,47].  
    Functional characterisation of enzymes involved in the LC-PUFA biosynthetic 
pathway in zebrafish including C≥24 allows us to predict all the conversions 
occurring from dietary essential C18 PUFA, 18:3n-3 and 18:2n-6 (Fig. 9). Together 
with desaturation and elongation steps performed by the dual ∆6/∆5 fatty acyl 
desaturase (∆6/∆5Fad) [33], and the two elongases Elovl5 [34] and Elovl2 [43], the 
newly characterised Elovl4 proteins augment the scheme, with Elovl4a able to 
elongate C20 PUFAs, whilst Elovl4b can elongate C22 and even longer PUFA, 
appearing as the primary elongase for the production of VLC-PUFA in zebrafish. 
Although mouse ELOVL2 has been shown to participate in the synthesis of n-6 VLC-
PUFA in testis [48], the zebrafish orthologue only produces products up to C26, with 
minor rates beyond that [43]. It is interesting to note that D. rerio Elovl4b has activity 
towards 20:5n-3 and 22:5n-3 but not DHA, the latter being only marginally elongated. 
This is consistent with previous investigations in mammalian retina where 
radiolabeled 20:5n-3 or 22:5n-3 were actively elongated, whereas DHA remained 
essentially unmodified and was directly esterified into phospholipids without further 
metabolism [49,50]. Although not directly tested in the present study, similar 
conversion patterns are expected to occur for the n-6 series, with 20:4n-6 and 22:4n-6 
but not 22:5n-6 being elongated to VLC-PUFA (Fig. 9). 
    Differences in the AA sequences of the Elovl4a and Elovl4b proteins might be the 
basis of the distinct functional roles discussed above. Phylogenetic analyses revealed 
that teleost Elovl4 proteins, besides clustering separately from other vertebrate 
Elovl4s, form two separate groups themselves, with zebrafish Elovl4a and Takifugu 
rubripes Elovl4 separated from zebrafish Elovl4b and Tetraodon nigroviridis Elovl4. 
Indeed, identity scores within each group (81.1% and 82.4 %, respectively) are higher 
than that between zebrafish Elovl4a and Elovl4b (73.8 % identity). These results, 
together with the different substrate specificities and embryonic expression patterns 
shown by zebrafish Elovl4s, suggest that, whereas Elovl4b is a common Elovl4-like 
protein similar to mammalian orthologues, zebrafish Elovl4a may represent a distinct 
member of the Elovl protein family in D. rerio, that may possibly extend to other 
teleosts. Cloning and functionally characterisation of further Elovl4 elongases from 
fish are required to confirm this possibility. 
    Elovl4 has been considered a crucial gene in early development of vertebrates. In 
addition to its role in the synthesis of important components for normal skin 
permeability barrier in mammals, essentiality of Elovl4 in early developmental stages 
has been indicated by the fact that it is expressed prior to organogenesis in mouse 
embryos [51]. Similarly, our data confirm that both elovl4a and elovl4b are expressed 
before early organogenesis in zebrafish, which occurs from segmentation period (10 
hpf) [32]. Moreover, zebrafish elovl4a and elovl4b transcripts are evident throughout 
embryogenesis of zebrafish, including stages before midblastula transition (512 cell 
stage, 2.75 hpf) when embryonic gene activation occurs [32]. Therefore, maternal 
transfer of mRNA occurs for both elovl4 genes, as previously reported for genes 
involved in the biosynthesis of LC-PUFA from dietary essential 18:3n-3 and 18:2n-6 
[43]. The maternal role can thus expand beyond the deposition of preformed C20-22 
LC-PUFA and, possibly, VLC-PUFA in the yolk, by transferring mRNA transcripts 
that can potentially be translated to active proteins. 
    Preliminary data from zebrafish transcriptome in situ hybridisation screening had 
suggested that the putative elovl4 genes showed different spatial-temporal expression 
patterns during embryonic development [52]. This is now confirmed by our WISH 
analyses. Zebrafish elovl4a is expressed in neuronal tissues from 24 hpf onwards, 
with possibly CNS and cranial ganglia being active metabolic tissues [53]. A similar 
expression pattern was previously shown for elovl5 and the dual ∆6/∆5fad [43], both 
genes encoding enzymes involved in LC-PUFA biosynthesis [54]. In adulthood 
elovl4a expression spreads to most tissues including liver, the latter not being 
generally regarded as a major metabolic site for the synthesis of VLC-FA [17,44,51]. 
This further suggests that zebrafish Elovl4a differs from mammalian orthologues, 
whose expression is essentially restricted to retina, brain, skin and testis [17,51]. 
    During embryonic development zebrafish elovl4b mRNA localises specifically in 
retina and epiphysis (pineal gland). These findings are in agreement with 
transcriptome analyses of zebrafish retina [55] and pineal gland [56] demonstrating 
the presence of elovl4b mRNA in early developmental stages. Teleostei retina and 
epiphysis have been hypothesised to have a common evolutionary origin [57], with 
both tissues possessing photoreceptor cells where expression of elovl4 genes are 
likely to occur [51,55,58]. Thus we present compelling evidence that, similar to 
mammals, zebrafish photoreceptor cells actively express elovl4b from embryonic 
stages. Although expression in pinealocyte photoreceptors could not be characterised, 
the results suggest a prominent metabolic role of epiphysis from early developmental 
stages, thus expanding the capacity of C20-22 PUFA metabolism in adult fish [59,60]. 
Expression of elovl4b remains in adult fish epiphysis [56], and also extends to other 
tissues with ovaries and testes showing strong expression signals. 
    Overall our results demonstrate that the two Elovl4 proteins found in zebrafish 
show marked differences in specificity and expression. Whereas Elovl4b resembles 
other mammalian orthologues in terms of function and expression patterns, Elovl4a 
may represent an alternative elongase not yet described in vertebrates and whose 
physiological roles require further investigation.  
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Figures 
 
Fig. 1. ClustalW2 alignment of the deduced amino acid sequences of zebrafish 
Elovl4a and Elovl4b. Identical residues are shaded black and similar residues (based 
on the Gonnet matrix, using ClustalW2 default parameters) are shaded grey. Indicated 
are the conserved histidine box motif HXXHH, five (I-V) putative membrane-
spanning domains, and the putative endoplasmic reticulum (ER) retrieval signal [58].  
 Fig. 2. Phylogenetic tree comparing zebrafish Elovl4 proteins, with other Elovl4 
orthologues, Elovl2- and Elovl5-like elongases. The tree was constructed using the 
Neighbour Joining method [36] with MEGA4. The horizontal branch length is 
proportional to amino acid substitution rate per site. The numbers represent the 
frequencies (%) with which the tree topology presented was replicated after 1000 
iterations. 
 Fig. 3. Role of zebrafish Elovl4 elongases in the biosynthesis of saturated very long-
chain fatty acids (VLC-FA). Yeast (Saccharomyces cerevisiae) transformed with 
pYES2 vector containing the ORF of elovl4a (A) and elovl4b (B) as inserts were 
grown in the presence of lignoceric acid 24:0, and fatty acid composition determined. 
Substrate 24:0 (“*”) and its corresponding elongated products are indicated 
accordingly. Saturated VLC-FA from control yeast transformed with empty pYES2 
are shown in panel C. Vertical axis, FID response; horizontal axis, retention time. 
 
Fig. 4. Role of zebrafish Elovl4b elongase in the biosynthesis of very long-chain fatty 
acids (VLC-PUFA). Yeast (S. cerevisiae) transformed with pYES2 vector containing 
the ORF of elovl4b as insert were grown in the presence of PUFA substrates 20:5n-3 
(A), 22:5n-3 (B) and 22:6n-3 (C), and fatty acid composition determined. Substrates 
(“*”) and their corresponding elongated products are indicated accordingly in panels 
A-F. Vertical axis, FID response; horizontal axis, retention time. 
 
Fig. 5. RT-PCR analyses of the temporal expression patterns of elovl4a and elovl4b 
during zebrafish early embryogenesis (0 hours to 7 days post-fertilisation at 28.5 ºC). 
Expression of the housekeeping gene β-actin is also shown. h, hours post-fertilisation; 
d, days post-fertilisation; NTC, no template control. 
!
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Fig. 6. Whole-mount in situ hybridisation showing the expression patterns of elovl4a 
in 48 hpf embryos. Embryos were hybridised with either antisense (A) or sense 
probes (B). Strong signal was observed in the head region of 48 hpf embryos when 
antisense probe was used (A), but no signal was observed for sense probe (B). Lateral 
views, dorsal upward, anterior to the left. Abbreviations: e: eye. Scale bars: 100 µm. 
 Fig. 7. Spatial-temporal expression pattern of elovl4b by whole-mount in situ 
hybridisation. A, B: Elovl4b transcripts appear at 24 hpf in the pineal gland and 
remain in this site until around 48 hpf (black arrows). Lateral view, anterior left up. 
C-E: Lateral view, anterior left up of 48 hpf embryos shown in (C). Arrows point to 
the pineal gland and ventral area of the retina expression. (D) Dorsal view, anterior up 
of 48 hpf embryo of elovl4b staining the pineal gland (black arrows). (E) ventral 
view, anterior up of 48 hpf embryo of elovl4b staining in the ventral area of 
developing retina (black arrows). F, G: Elovl4b expression in the retinal epithelium 
(black arrows) is localised ventrally at the edges (72 hpf). Lateral view, anterior left 
up (F) and ventral view, anterior up (G). H: At 72 hpf, the strongest elovl4b 
expression is present in the ventral portion of the retina photoreceptor cell layer, in the 
so-called ‘‘ventral patch’’ (arrowheads). Lateral view, anterior up. No signal was 
detected for sense control probes (data not shown). Abbreviations: e, eye; le, lens; pcl, 
photoreceptor cell layer; inl, inner nuclear layer; gcl, ganglion cell layer; pe, pigment 
epithelium.  Scale bars: 100 µm (A,B,C,D,E,F,G), 25 µm (H).	  
 Fig. 8. RT-PCR analyses showing the tissue distribution of elovl4a and elovl4b 
transcripts in zebrafish adults. Expression of the housekeeping gene β-actin is also 
shown. NTC, no template control. 
 
Fig. 9. The long-chain polyunsaturated fatty acid biosynthetic pathway from 18:3n-3 
and 18:2n-6. Enzymatic activities shown in the scheme are predicted from 
heterologous expression in S. cerevisiae of the dual ∆6/∆5 fatty acyl desaturase 
(∆6/∆5Fad) [33], and Elovl5 [34] and Elovl2 [43] elongases. Steps catalysed by the 
newly characterised Elovl4a and Elovl4b are also shown. 
 
Tables 
Table 1. Sequence of the primer pairs used, size of the fragment produced and 
accession number of the sequence used as reference for primer design, for elovl4 
ORFs cloning and reverse transcriptase PCR (RT-PCR) performed in zebrafish 
embryos and adult tissues.  
 
Table 2. Functional characterisation of zebrafish Elovl4 elongases: Role in 
biosynthesis of very long-chain saturated fatty acids (FA). Results are expressed as an 
area percentage of total saturated FA C≥24 found in yeast transformed with either 
zebrafish elovl4 ORFs or empty pYES2 vector (Control). 
 
         
 FA  Elovl4a  Elovl4b  Control  
         
 24:0*  5.3  5.5  9.2  
 26:0  38.5  42.9  80.2  
 28:0  22.3  33.7  7.5  
 30:0  19.2  14.1  1.4  
 32:0  10.8  2.8  0.8  
 34:0  3.3  0.7  0.9  
 36:0  0.6  0.2  0.0  
         
* Lignoceric acid used as exogenously added substrate. 
 
Table 3. Functional characterisation of zebrafish Elovl4 elongases: conversions on 
polyunsaturated fatty acid (FA) substrates. Results are expressed as a percentage of 
total FA substrate converted to elongated product. Percentage of stepwise conversion 
into intermediary products of the elongation pathway is also shown. 
           
 FA substrate  Product  Elovl4a  Elovl4b  Activity  
           
 20:5n-3  22:5n-3  11.2  9.2  C20→22  
   24:5n-3  2.8  3.3  C22→24  
   26:5n-3  0.4  0.4  C24→26  
   28:5n-3  0.0  0.1  C26→28  
   30:5n-3  0.0  1.3  C28→30  
   32:5n-3  0.2  11.6  C30→32  
   34:5n-3  0.7  7.8  C32→34  
   36:5n-3  0.5  0.4  C34→36  
   Total  16.0  34.1    
           
 20:4n-6  22:4n-6  11.5  9.0  C20→22  
   24:4n-6  4.6  3.5  C22→24  
   26:4n-6  1.0  0.8  C24→26  
   28:4n-6  0.0  0.4  C26→28  
   30:4n-6  0.2  4.7  C28→30  
   32:4n-6  0.5  16.9  C30→32  
   34:4n-6  2.6  2.8  C32→34  
   36:4n-6  0.0  0.0  C34→36  
   Total  20.3  38.1    
           
 22:5n-3  24:5n-3  3.8  5.5  C22→24  
   26:5n-3  0.4  0.6  C24→26  
   28:5n-3  0.0  0.2  C26→28  
   30:5n-3  0.0  1.7  C28→30  
   32:5n-3  0.2  14.3  C30→32  
   34:5n-3  0.5  7.2  C32→34  
   36:5n-3  0.3  0.2  C34→36  
   Total  5.2  29.8    
           
 22:4n-6  24:4n-6  3.4  3.6  C22→24  
   26:4n-6  0.7  0.4  C24→26  
   28:4n-6  0.0  0.2  C26→28  
   30:4n-6  0.1  2.8  C28→30  
   32:4n-6  0.4  12.5  C30→32  
   34:4n-6  2.2  3.6  C32→34  
   36:4n-6  0.0  0.0  C34→36  
   Total  6.8  23.1    
           
 22:6n-3  24:6n-3  0.2  0.6  C22→24  
   26:6n-3  0.0  0.0  C24→26  
   28:6n-3  0.0  0.0  C26→28  
   30:6n-3  0.0  0.1  C28→30  
   32:6n-3  0.0  1.4  C30→32  
   34:6n-3  0.0  0.5  C32→34  
   36:6n-3  0.0  0.0  C34→36  
   Total  0.2  2.7    
              
 
 
